Pharmanext’s portfolio has been expanded with Octeangin®

From September 2023, our company represents Klosterfrau’s Octeangin® in Hungary, which is the only patented lozenge containing octenidine dihydrochloride on the market.
Octeangin® 2.6 mg lozenges are recommended for the short-term adjunctive treatment of inflammation of the mouth and throat mucosa with typical symptoms such as pain, redness and swelling.

The product’s introduction was primarily facilitated through targeted professional communication channels. Additionally, a compelling consumer sponsorship initiative has been undertaken, notably featuring in RTL’s Sztárbox, enhancing the product’s visibility and market presence. 🥊

Octeangin® 2.6 mg tablets, 20x: Octaindine dihydrochloride, available without a prescription.
Distributed in Hungary by Pharmanext Kft. – 1085 Budapest, Stáhly u. 2/a – info@pharmanext.hu – www.octeangin.hu